Skip to Main Content

Author Details

Franklin R Toapanta
University of Maryland School of Medicine
2004
33
17
PMIDPaper TitleJournal TitlePublished Year
37207226Reduced immunogenicity of a live <i>Salmonella enterica</i> serovar Typhimurium vaccine in aged mice.Front Immunol2023
38022674Further characterization of <i>Shigella</i>-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a <i>Shigella flexneri</i> 2a synthetic glycan-based vaccine candidate.Front Immunol2023
35650631Altered transcriptional responses in the lungs of aged mice after influenza infection.Immun Ageing2022
33419014B and T Cell Immunity in Tissues and Across the Ages.Vaccines (Basel)2021
34310885Immunogenicity and Efficacy of Live-Attenuated <i>Salmonella</i> Typhimurium Vaccine Candidate CVD 1926 in a Rhesus Macaque Model of Gastroenteritis.Infect Immun2021
32355503The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route.Immun Ageing2020
33229108Understanding immunosenescence and its impact on vaccination of older adults.Vaccine2020
31230883Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.Vaccine2019
29304144A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.PLoS One2018
30188914Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.PLoS One2018
29672646Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.PLoS One2018
29534721T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans.J Transl Med2018
28904202Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.J Virol2017
27300136Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease.PLoS Negl Trop Dis2016
25843213The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study.J Theor Biol2015
26473911Modeling Influenza Virus Infection: A Roadmap for Influenza Research.Viruses2015
26065687Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease.PLoS Negl Trop Dis2015
24478442Effects of aging on influenza virus infection dynamics.J Virol2014
25191323Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Front Immunol2014
24995010Characterization and functional properties of gastric tissue-resident memory T cells from children, adults, and the elderly.Front Immunol2014
23589755Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics.PLoS One2013
23755118Differential response of the cynomolgus macaque gut microbiota to Shigella infection.PLoS One2013
22037624Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza.Immunol Lett2012
23087912Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level.Front Cell Infect Microbiol2012
21385589An agent-based model of inflammation and fibrosis following particulate exposure in the lung.Math Biosci2011
20064559C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2.Immunol Lett2010
19922665Impaired immune responses in the lungs of aged mice following influenza infection.Respir Res2009
18231588Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.PLoS One2008
17337102Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.Vaccine2007
17346134Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope.Curr HIV Res2007
17337780Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.Immunol Res2006
15128761Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression.J Immunol2004
15068861Mouse strain-dependent differences in enhancement of immune responses by C3d.Vaccine2004
  • 1 - 33 of 33

Recommended Authors

Rishi R Goel
Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Blake Frey
University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
Laura Campisi
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 0
Alison Deckhut Augustine
National Institute of Allergy and Infectious Diseases/National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
John T Bates
University of Mississippi Medical Center
Career Start Year 2005
Number of shared co-authors 0
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Michele A Kutzler
Drexel University College of Medicine
Career Start Year 2004
Number of shared co-authors 0
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 1
Junghee J Shin
Yale University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Subhasis Mohanty
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Janko Nikolich-Zugich
University of Arizona Center on Aging, University of Arizona
Career Start Year 2000
Number of shared co-authors 0
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 3
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Michelle A Gill
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 0
Gr??goire Lauvau
Albert Einstein College of Medicine
Career Start Year 1998
Number of shared co-authors 0
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Tobias R Kollmann
Telethon Kids Institute
Career Start Year 1991
Number of shared co-authors 0
Liise-Anne Pirofski
Albert Einstein College of Medicine, Montefiore Medical Center
Career Start Year 1990
Number of shared co-authors 0
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 0
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 1
Anne S De Groot
University of Georgia
Career Start Year 1989
Number of shared co-authors 1
Albert C Shaw
Yale School of Medicine, Yale University
Career Start Year 1987
Number of shared co-authors 0
Gregory A Poland
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 0
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 2
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Co-authored papers 13
G Clermont
University of Pittsburgh
Co-authored papers 2
Ian Price
University of Pittsburgh
Co-authored papers 2
Ericka Mochan
Carlow University
Co-authored papers 2
David Swigon
University of Pittsburgh
Co-authored papers 2
George Ermentrout
University of Pittsburgh
Co-authored papers 2
Emiley A Eloe-Fadrosh
DOE Joint Genome Institute, Lawrence Berkeley National Laboratory
Co-authored papers 1
Li Ang Zhang
University of Pittsburgh
Co-authored papers 1
Robert S Parker
University of Pittsburgh
Co-authored papers 1
David R Karp
University of Texas Southwestern Medical Center
Co-authored papers 1
Claire M Fraser
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 1
Terrence M Tumpey
Centers for Disease Control and Prevention.
Co-authored papers 1
Yoram Vodovotz
University of Pittsburgh
Co-authored papers 1
Michael Matuszewski
University of Pittsburgh
Co-authored papers 1
Alisa Urbano
University of Pittsburgh
Co-authored papers 1
Meagan E Deming
University of Maryland School of Medicine
Co-authored papers 1
Sarah Lukens
University of Pittsburgh
Co-authored papers 1
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 1
Release 1.2